Evaluation of anti-Xa monitoring in children receiving enoxaparin in a cardiac intensive care unit

被引：0
|
作者：
Engdahl, Samantha [1 ]
Corcoran, Jason [1 ]
机构：
[1] Childrens Natl Med Ctr, Dept Pharm, Washington, DC 20010 USA
来源：
PHARMACOTHERAPY | 2014年 / 34卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
136
引用
收藏
页码：E112 / E112
页数：1
相关论文
共 50 条
  • [21] EVALUATION OF ANTI-XA TARGET ATTAINMENT WITH PROPHYLACTIC ENOXAPARIN DOSING REGIMENS IN OBESITY
    Sabers, Andrew
    Reynolds, Brandon
    Langenhan, Emilie
    [J]. CRITICAL CARE MEDICINE, 2023, 51 (01) : 364 - 364
  • [22] Anti-Xa stability of diluted enoxaparin for use in pediatrics
    Dager, WE
    Gosselin, RC
    King, JH
    Christensen, CL
    Owings, JT
    Larkin, EC
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (04) : 569 - 573
  • [23] Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity
    Nameer van Oosterom
    Karl Winckel
    Michael Barras
    [J]. Journal of Thrombosis and Thrombolysis, 2019, 48 : 387 - 393
  • [24] Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity
    van Oosterom, Nameer
    Winckel, Karl
    Barras, Michael
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (03) : 387 - 393
  • [25] Development and evaluation of PEGylated Enoxaparin: A novel approach for enhanced anti-Xa activity
    Choubey, Anupam Kumar
    Dora, Chander Parkash
    Bhatt, Tara Dutt
    Gill, Manjinder Singh
    Suresh, Sarasija
    [J]. BIOORGANIC CHEMISTRY, 2014, 54 : 1 - 6
  • [26] Assessment of enoxaparin anti-Xa activity and treatment efficacy's evaluation.
    Bounda, Guy-Armel
    Hui, Hao Zhi
    Hong, Wei
    Yu, Feng
    [J]. PHARMACOTHERAPY, 2013, 33 (05): : E57 - E57
  • [27] Non-therapeutic anti-Xa levels in medical patients receiving anticoagulant therapy with enoxaparin
    Ramos-Esquivel, Allan
    Salazar-Sanchez, Lizbeth
    [J]. THROMBOSIS RESEARCH, 2013, 132 (04) : 433 - 436
  • [28] IMPACT OF WEIGHT ON ANTI-XA IN HIGH-RISK TRAUMA PATIENTS RECEIVING ENOXAPARIN CHEMOPROPHYLAXIS
    Farrar, Julie
    Droege, Molly
    Philpott, Carolyn
    Mueller, Eric
    Ernst, Neil
    Makley, Amy
    Deichstetter, Kaley
    Droege, Christopher
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 673 - 673
  • [29] Anti-Xa monitoring in critically ill patients with normal renal function on therapeutic enoxaparin
    Sargent, Kathleen M.
    Robbins, Adele
    Njoroge, Milka W.
    Donovan, Jennifer L.
    Tran, Maichi T.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 35 (03) : 404 - 404
  • [30] Enoxaparin dosing in advanced chronic kidney disease: importance of monitoring with anti-Xa levels
    Cases Corona, Clara Maria
    Lopez Melero, Eva
    Landaluce Triska, Eugenia
    Leon, Mariana
    Roldan, Deborah
    Gruss, Enrique
    Shabaka, Amir
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2323 - I2323
12345